1)日本脳卒中学会,日本循環器学会,日本心血管インターベンション治療学会:潜因性脳梗塞に対する経皮的卵円孔開存閉鎖術の手引き.日本循環器学会,2019
2)Saver JL, Carroll JD, Thaler DE, et al : Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke. N Engl J Med 377 : 1022-1032, 2017
3)Sondergaard L, Kasner SE, Rhodes JF, et al : Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke. N Engl J Med 377 : 1033-1042, 2017
4)Mas JL, Derumeaux G, Guillon B, et al : Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke. N Engl J Med 377 : 1011-1021, 2017
5)Kasner SE, Rhodes JF, Andersen G, et al : Five-Year Outcomes of PFO Closure or Antiplatelet Therapy for Cryptogenic Stroke. N Engl J Med 384 : 970-971, 2021
6)日本脳卒中学会 脳卒中ガイドライン委員会(編):脳卒中治療ガイドライン2021.協和企画,2021
7)Takaya Y, Nakayama R, Akagi T, et al : Importance of saline contrast transthoracic echocardiography for evaluating large right-to-left shunt in patent foramen ovale associated with cryptogenic stroke. Int J Cardiovasc Imaging 38 : 515-520, 2022
8)Takaya Y, Watanabe N, Ikeda M, et al : Importance of Abdominal Compression Valsalva Maneuver and Microbubble Grading in Contrast Transthoracic Echocardiography for Detecting Patent Foramen Ovale. J Am Soc Echocardiogr 33 : 201-206, 2020
9)Nakayama R, Takaya Y, Akagi T, et al : Identification of High-Risk Patent Foramen Ovale Associated With Cryptogenic Stroke : Development of a Scoring System. J Am Soc Echocardiogr 32 : 811-816, 2019
10)Turc G, Lee JY, Brochet E, et al : Atrial Septal Aneurysm, Shunt Size, and Recurrent Stroke Risk in Patients With Patent Foramen Ovale. J Am Coll Cardiol 75 : 2312-2320, 2020
11)Takaya Y, Nakayama R, Akagi T, et al : Importance of direct right-to-left shunt as high-risk patent foramen ovale associated with cryptogenic stroke. Echocardiography 38 : 1887-1892, 2021
12)Kwon H, Lee PH, Song JK, et al : Patent Foramen Ovale Closure in Old Stroke Patients : A Subgroup Analysis of the DEFENSE-PFO Trial. J Stroke 23 : 289-292, 2021